Back

Cholesterol paradox in atrial fibrillation: is it solved in lipid-lowering drugs users?

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Primary Care & Risk Factor Management Lipids Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mr Bartlomiej Bartos

SGMK Copernicus University, Olsztyn (Poland)

4 More presentations in this session

Presentation thumbnail
Early insulin resistance in low-risk subjects with normal glycemia is associated with subclinical atherosclerosis
Doctor J. Iglesies-Grau (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Development, validation and prospective clinical implementation of a machine learning algorithm for incident cardio-renal-metabolic diseases and cardiovascular death: the OPTIMISE study.
Doctor R. Nadarajah (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Comparative effectiveness of non-pharmacological interventions on metabolic syndrome and its components: a systematic review and network meta-analysis
Ms B. Chan (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort.
Doctor C. Luz Goulart (Porto Alegre, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Primary Care & Risk Factor Management

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Lipidomics to fine-tune cardiovascular risk prediction and personalised treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources